Enzo Biochem Previously Paid Three States $4.5M in Fines for Same BreachBiotech firm Enzo Biochem has agreed to pay $7.5 million to settle a consolidated proposed class action lawsuit involving a 2023 ransomware attack affecting 2.5 million people. The company has already paid $4.5 million in fines to three state attorneys general for the same incident.
Enzo is a New York-based biotechnology company that develops diagnostics tests for the treatment of cancer, diabetes, HIV, uveitis, and inflammatory bowel diseases.